| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $10,0650 | +0,25% | $317,37M | $104,23K | |
FUND Sprott Focus Trust, Inc. | $10,9300 | +0,46% | $317,19M | $8,94K | |
FATE Fate Therapeutics, Inc. | $2,4500 | +5,15% | $317,04M | $1,31M | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1,5250 | -6,44% | $316,83M | $1,15M | |
GALT Galectin Therapeutics Inc. | $3,8750 | +5,30% | $316,66M | $227,96K | |
NREF NexPoint Real Estate Finance, Inc. | $17,5900 | +2,99% | $316,64M | $47,51K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10,8100 | -0,19% | $316,34M | $1,31K | |
PSBD Palmer Square Capital BDC Inc. | $10,3800 | +1,07% | $316,32M | $55,62K | |
| $3,1100 | -4,01% | $316,09M | $457,40K | |
| $6,4300 | -0,62% | $315,88M | $95,99K | |
SMTI Sanara MedTech Inc. Common Stock | $34,3900 | -0,17% | $315,59M | $460,11K | |
MLP Maui Land & Pineapple Co. | $15,7600 | +0,64% | $315,56M | $19,27K | |
AFB Alliance National Municipal Income Fund, Inc. | $10,9300 | +0,18% | $315,33M | $19,91K | |
| $40,9900 | -0,02% | $315,30M | $14,39K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10,5400 | +0,05% | $315,30M | $71,01K | |
